I

Isosceles Pharmaceuticals

9 employees

Isosceles Pharmaceuticals is a preclinical stage biotech company that is working on perioperative acute pain product candidates.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Small Molecule
FDA
Addiction Medicine
Biotech
Global Health
Intravenous
Opioid Crisis
Acute Pain
Unmet Need
Clinical Development
Transdermal
Medicine
Analgesia
Postoperative Pain
Non NSAID
Non-Opioid
Inflammatory Disease
Pain Therapy

Date founded

2019

Funding rounds raised

Total raised

$5M

from 1 investors over 1 rounds

I

Isosceles Pharmaceuticals raised $5M on October 3, 2022

Investors: Equifund

FAQ